YIH
CALA

Y-Intercept (HK)’s Calithera Biosciences, Inc CALA Stock Holding History

Y-Intercept (HK)’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-819
Closed -$34K – 997
2021
Q2 		$34K Buy
+819
New +$36K 0.01% 572

Other funds holding CALA

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DMPV
Delphi Management Partners VIII San Mateo, California $138M AUM 56.74% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Y-Intercept (HK)'s CALA Position: Q3 2021 in Review

Y-Intercept (HK) sold out of Calithera Biosciences, Inc (CALA) in Q3 2021, closing a stake of 819 shares — an estimated $34K sold.

Y-Intercept (HK) first reported a position in CALA in Q2 2021 and held it in 1 quarter. The position peaked at $34K in Q2 2021. 66 funds tracked by Wall St. Rank hold CALA as of Q3 2021.

  • Y-Intercept (HK) reported no remaining Calithera Biosciences, Inc position as of Q3 2021 after selling out during the quarter.
  • Y-Intercept (HK) sold 819 Calithera Biosciences, Inc shares in Q3 2021, an estimated $34K.
  • Y-Intercept (HK) first reported a position in Calithera Biosciences, Inc in Q2 2021 and held it in 1 quarter.
  • Y-Intercept (HK)'s Calithera Biosciences, Inc position peaked at $34K in Q2 2021.
  • 66 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q3 2021.

Based on Y-Intercept (HK)'s 13F filing for Q3 2021, filed 15 Nov 2021.